These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26438304)

  • 1. Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - NO.
    Scalfari A
    Mult Scler; 2015 Oct; 21(11):1371-4. PubMed ID: 26438304
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - YES.
    Scott TF
    Mult Scler; 2015 Oct; 21(11):1369-71. PubMed ID: 26438303
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple sclerosis relapse phenotype is an important, neglected determinant of disease-outcome: Commentary.
    Hutchinson M
    Mult Scler; 2015 Oct; 21(11):1374-5. PubMed ID: 26438305
    [No Abstract]   [Full Text] [Related]  

  • 4. Relapse, remission, and progression in multiple sclerosis.
    McDonald WI
    N Engl J Med; 2000 Nov; 343(20):1486-7. PubMed ID: 11078776
    [No Abstract]   [Full Text] [Related]  

  • 5. Modeling the course and outcomes of multiple sclerosis is statistical twaddle--Yes.
    Taylor BV
    Mult Scler; 2016 Feb; 22(2):140-2. PubMed ID: 26830393
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis.
    Sotgiu S; Mameli G; Serra C; Zarbo IR; Arru G; Dolei A
    Mult Scler; 2010 Oct; 16(10):1248-51. PubMed ID: 20685761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the course and outcomes of MS is statistical twaddle--No.
    Bergamaschi R; Montomoli C
    Mult Scler; 2016 Feb; 22(2):142-4. PubMed ID: 26830394
    [No Abstract]   [Full Text] [Related]  

  • 8. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.
    Confavreux C; Hutchinson M; Hours MM; Cortinovis-Tourniaire P; Moreau T
    N Engl J Med; 1998 Jul; 339(5):285-91. PubMed ID: 9682040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
    Chard D; Miller D
    J Neurol Sci; 2009 Jul; 282(1-2):5-11. PubMed ID: 19201002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome measures in multiple sclerosis clinical trials.
    Andersson PB; Goodkin DE
    Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: relapses and timing of remissions.
    Iuliano G; Napoletano R; Esposito A
    Eur Neurol; 2008; 59(1-2):44-8. PubMed ID: 17917457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pregnancy and delivery on disease activity in multiple sclerosis.
    Whitaker JN
    N Engl J Med; 1998 Jul; 339(5):339-40. PubMed ID: 9682048
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving reporting of multiple sclerosis relapse.
    Roberts M; Lush T; Pohorely J
    Nurs Times; 2015 Nov 25-Dec 1; 111(48):12-4. PubMed ID: 26775329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early treatment of multiple sclerosis to prevent neurologic damage.
    Coyle PK
    Neurology; 2008 Dec; 71(24 Suppl 3):S3-7. PubMed ID: 19064872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O; Fernández V; De Ramón E
    J Neurol Sci; 2004 Aug; 223(1):29-34. PubMed ID: 15261557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of relapse phenotype recurrence in multiple sclerosis.
    Kalincik T; Buzzard K; Jokubaitis V; Trojano M; Duquette P; Izquierdo G; Girard M; Lugaresi A; Grammond P; Grand'Maison F; Oreja-Guevara C; Boz C; Hupperts R; Petersen T; Giuliani G; Iuliano G; Lechner-Scott J; Barnett M; Bergamaschi R; Van Pesch V; Amato MP; van Munster E; Fernandez-Bolanos R; Verheul F; Fiol M; Cristiano E; Slee M; Rio ME; Spitaleri D; Alroughani R; Gray O; Saladino ML; Flechter S; Herbert J; Cabrera-Gomez JA; Vella N; Paine M; Shaw C; Moore F; Vucic S; Savino A; Singhal B; Petkovska-Boskova T; Parratt J; Sirbu CA; Rozsa C; Liew D; Butzkueven H;
    Mult Scler; 2014 Oct; 20(11):1511-22. PubMed ID: 24777276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconsidering clinical outcomes in Multiple Sclerosis: relapses, impairment, disability and beyond.
    D'Souza M; Kappos L; Czaplinski A
    J Neurol Sci; 2008 Nov; 274(1-2):76-9. PubMed ID: 18817932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of multiple sclerosis with childhood onset.
    Renoux C; Vukusic S; Confavreux C
    Clin Neurol Neurosurg; 2008 Nov; 110(9):897-904. PubMed ID: 18534742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy and multiple sclerosis. An Australian perspective.
    Frith JA; McLeod JG
    Clin Exp Neurol; 1987; 24():1-4. PubMed ID: 3268333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impairment, disability and handicap scales in multiple sclerosis].
    Arbizu-Urdiain T; Martínez-Yélamos A; Casado Ruiz V
    Rev Neurol; 2002 Dec 1-15; 35(11):1081-93. PubMed ID: 12497316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.